Cargando…

Application of Solid-Phase Extraction and High-Performance Liquid Chromatography with Fluorescence Detection to Analyze Eleven Bisphenols in Amniotic Fluid Samples Collected during Amniocentesis

Amniocentesis involves taking a sample of the amniotic fluid in order to perform a karyotype test and diagnose any genetic defects that may affect the fetus. Amniotic fluid has been collected from patients with an indication for amniocentesis in the 15–26th week of pregnancy. A simple and sensitive...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuzimski, Tomasz, Szubartowski, Szymon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8872576/
https://www.ncbi.nlm.nih.gov/pubmed/35206500
http://dx.doi.org/10.3390/ijerph19042309
_version_ 1784657271536484352
author Tuzimski, Tomasz
Szubartowski, Szymon
author_facet Tuzimski, Tomasz
Szubartowski, Szymon
author_sort Tuzimski, Tomasz
collection PubMed
description Amniocentesis involves taking a sample of the amniotic fluid in order to perform a karyotype test and diagnose any genetic defects that may affect the fetus. Amniotic fluid has been collected from patients with an indication for amniocentesis in the 15–26th week of pregnancy. A simple and sensitive high-performance liquid chromatography with fluorescence detection (HPLC-FLD) method for identification and quantification of eleven selected bisphenols in amniotic fluid samples is proposed. The proposed method involved protein precipitation using acetonitrile, and next the extraction and concentration of analytes by solid-phase extraction (SPE). The solid-phase extraction (SPE) procedure with application of Oasis HLB SPE columns performed well for the majority of the analytes, with recoveries in the range of 67–121% and relative standard deviations (RSD%) less than 16%. The limits of detection (LODs) and quantification (LOQs) of all the investigated analytes were in the range of 0.8–2.5 ng mL(−1) and 2.4–7.5 ng mL(−1) (curves constructed in methanol) and 1.1–5.2 ng mL(−1) and 3.2–15.6 ng mL(−1) (curves constructed in the amniotic fluid), respectively. The method was validated at the following two concentration levels: 10 ng mL(−1) (2 × LOQ) and 20 ng mL(−1) (4 LOQ). The results confirm the validity of the SPE procedure and HPLC-FLD method for identification and quantification of bisphenols in amniotic fluid samples collected during an amniocentesis. The result obtained show that HPLC-FLD is a useful method for determination of bisphenol residues at nanogram per milliliter concentrations in amniotic fluid samples. Residues of five analytes (BADGE·2H(2)O, BPAF, BADGE, BADGE·H(2)O·HCl and BADGE·2HCl) were detected in amniotic fluid samples. Additionally, the harmfulness of bisphenols as potential pathogens that may cause karyotype disorders and contribute to preterm birth was estimated.
format Online
Article
Text
id pubmed-8872576
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88725762022-02-25 Application of Solid-Phase Extraction and High-Performance Liquid Chromatography with Fluorescence Detection to Analyze Eleven Bisphenols in Amniotic Fluid Samples Collected during Amniocentesis Tuzimski, Tomasz Szubartowski, Szymon Int J Environ Res Public Health Article Amniocentesis involves taking a sample of the amniotic fluid in order to perform a karyotype test and diagnose any genetic defects that may affect the fetus. Amniotic fluid has been collected from patients with an indication for amniocentesis in the 15–26th week of pregnancy. A simple and sensitive high-performance liquid chromatography with fluorescence detection (HPLC-FLD) method for identification and quantification of eleven selected bisphenols in amniotic fluid samples is proposed. The proposed method involved protein precipitation using acetonitrile, and next the extraction and concentration of analytes by solid-phase extraction (SPE). The solid-phase extraction (SPE) procedure with application of Oasis HLB SPE columns performed well for the majority of the analytes, with recoveries in the range of 67–121% and relative standard deviations (RSD%) less than 16%. The limits of detection (LODs) and quantification (LOQs) of all the investigated analytes were in the range of 0.8–2.5 ng mL(−1) and 2.4–7.5 ng mL(−1) (curves constructed in methanol) and 1.1–5.2 ng mL(−1) and 3.2–15.6 ng mL(−1) (curves constructed in the amniotic fluid), respectively. The method was validated at the following two concentration levels: 10 ng mL(−1) (2 × LOQ) and 20 ng mL(−1) (4 LOQ). The results confirm the validity of the SPE procedure and HPLC-FLD method for identification and quantification of bisphenols in amniotic fluid samples collected during an amniocentesis. The result obtained show that HPLC-FLD is a useful method for determination of bisphenol residues at nanogram per milliliter concentrations in amniotic fluid samples. Residues of five analytes (BADGE·2H(2)O, BPAF, BADGE, BADGE·H(2)O·HCl and BADGE·2HCl) were detected in amniotic fluid samples. Additionally, the harmfulness of bisphenols as potential pathogens that may cause karyotype disorders and contribute to preterm birth was estimated. MDPI 2022-02-17 /pmc/articles/PMC8872576/ /pubmed/35206500 http://dx.doi.org/10.3390/ijerph19042309 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Tuzimski, Tomasz
Szubartowski, Szymon
Application of Solid-Phase Extraction and High-Performance Liquid Chromatography with Fluorescence Detection to Analyze Eleven Bisphenols in Amniotic Fluid Samples Collected during Amniocentesis
title Application of Solid-Phase Extraction and High-Performance Liquid Chromatography with Fluorescence Detection to Analyze Eleven Bisphenols in Amniotic Fluid Samples Collected during Amniocentesis
title_full Application of Solid-Phase Extraction and High-Performance Liquid Chromatography with Fluorescence Detection to Analyze Eleven Bisphenols in Amniotic Fluid Samples Collected during Amniocentesis
title_fullStr Application of Solid-Phase Extraction and High-Performance Liquid Chromatography with Fluorescence Detection to Analyze Eleven Bisphenols in Amniotic Fluid Samples Collected during Amniocentesis
title_full_unstemmed Application of Solid-Phase Extraction and High-Performance Liquid Chromatography with Fluorescence Detection to Analyze Eleven Bisphenols in Amniotic Fluid Samples Collected during Amniocentesis
title_short Application of Solid-Phase Extraction and High-Performance Liquid Chromatography with Fluorescence Detection to Analyze Eleven Bisphenols in Amniotic Fluid Samples Collected during Amniocentesis
title_sort application of solid-phase extraction and high-performance liquid chromatography with fluorescence detection to analyze eleven bisphenols in amniotic fluid samples collected during amniocentesis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8872576/
https://www.ncbi.nlm.nih.gov/pubmed/35206500
http://dx.doi.org/10.3390/ijerph19042309
work_keys_str_mv AT tuzimskitomasz applicationofsolidphaseextractionandhighperformanceliquidchromatographywithfluorescencedetectiontoanalyzeelevenbisphenolsinamnioticfluidsamplescollectedduringamniocentesis
AT szubartowskiszymon applicationofsolidphaseextractionandhighperformanceliquidchromatographywithfluorescencedetectiontoanalyzeelevenbisphenolsinamnioticfluidsamplescollectedduringamniocentesis